ITU Experts Group Thierry Zylberberg, Executive Vice President Orange, General Manager of Orange Healthcare September 2012
Apr 01, 2015
ITU Experts Group
Thierry Zylberberg, Executive Vice President Orange, General Manager of Orange Healthcare
September 2012
2
agenda
part 1frameworks for m-health
part 2concrete case
part 3challenges and opportunities
3
reality…
Worldwide, between 2010 and 2050,
people aged 60 and more : +100 %1
People aged 80 and more : +100 %1
Between 2000 and 2050, share of the
dependent population: + 25 % in OECD countries
Spending for seniors to double or more by 2050,
says OECD
Chronic Disease Direct costs:Asthma: b$17.7 in Europe3
Diabetes: b$92 in USA3
Heart Failure: b$37 in USA4
Half of Brazil population said to have at least 1 chronic disease
In India, by 2015, 59% ofthe total deaths would
be due to NCDs
Healthcare expenditure in OECD countries +5%/year
France : 11% of GDPUSA : 15,3% of GDPGermany : 10,7% of
GDP says OCED
~30% of drugs of any given medicine can
be fake in Africa2
1 : accord the WHO, 20112 : according the WHO. (Source: The Times-UK, February, 2009)3: IDATE, sur la base du WHO 2009 ; OECD 2009 ; US Census 2009 ; Eurostat 20094: Home Monitoring for Heart Failure Management, Anh L. Bui, MD, Gregg C. Fonarow, MD Los Angeles, California, Journal of the American College of Cardiology Vol. 59, No. 2, 2012
1- frameworks for m-health
4
1- frameworks for m-health
technology…
low costs phenotypes
big datatechnologies
web 2.0, Internet
technologies
always ontechnologies
predictivemedicine
multiple factorstreatment or
diagnosis
be with the patienteverywhere,
anytime
patientempowerment
5
1- frameworks for m-health
Press & Portals
Web 2.0
CRM
New business model
Disruptive technologies
…in a complex ecosystem…
6
…a framework
health
professionals
patients
&
health professionals
patients
&
patients
BtoB
BtoGBtoC
business
model
medical data
compliance
medical medical consumerusage
Orange Healthcare©
Bto BG C
2
1- frameworks for m-health
7
business modelyet to
be found
healthaccess
healthefficiency
new busine
ss model
stablebusines
smodel
Cloud-Imagery
Drugs authentification
Health-line
ConnectedHospital
CDRMCloud-EHR
Health data hosting
Remote consultation (video
conf.)
DiabeticPatient follow
up
Appointment reminder
...another framework
1- frameworks for m-health
Toll-free emergency
Health surveys surveillance
8
Orange Value Chain
Health Applicati
ons
Healthcare ecosystem
Health “Computing”
(hosting)
PartnersPartners
Patients
Medical Devices
Consulting, Integration
M2M, International backbones &
Last mile
Global Integration, Helpdesk, services to end users
Specific developments (Security,
portals)
e-health, an ecosystem in mutation requires cooperation
1- frameworks for m-health
9
case 1 of partnership: Sanofi and Orange
2- concrete case
10
DiabeTIC Platform. Bidirectional communication between HCP & Patients
Mobile Computer
Patients with BGStar or iBGStar
Patient with other BGMs
Storage and analysis
HCPPATIENT
DNE
Available to all patients (not only i/BGStar patients)
2- concrete case
11 Orange Healthcare – TWC 2011
case 2 of partnership: mPedigree and Orange
2- concrete case
12
SMS based solution allowing to check if taken drug is counterfeit or authentic.
Easy-to-use solution, immediate response
Implemented in Kenya
counterfeit medicine solutionOrange and mPedigree are fighting counterfeit medicines
2- concrete case
13
challenges and opportunities
3- challenges and opportunities
1st challenge: business model
B2G or B2B2C or
B2C?
How can consumers be educated about and persuaded to use such a service?
How can pharmacist be incentivized
to positively promote such a service?Who will fund services?
Can pharmas finance services? Why?
Does a government need to constrain the installation of a
service ?
Is the system open to abuse – such as counterfeiters providing bogus SMS
checking numbers themselves?
What other kinds of similar services
could be developed?
3- challenges and opportunities
15
2nd challenge: dilution of responsibility, value chain complexity
Mobile Computer
Patients with BGStar or iBGStar
Patient with other BGMs
Storage and analysis
HCPPATIENT
DNE
connectivity
3- challenges and opportunities
16
3rd challenge: regulation
3- challenges and opportunities
17
Thank you